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Abstract
Background Three-dimensional view in laparoscopic general, gynaecologic and urologic surgery is an efficient, safe and 
sustainable innovation. The present paper is an extract taken from a full health technology assessment report on three-
dimensional vision technology compared with standard two-dimensional laparoscopic systems.
Methods A health technology assessment approach was implemented in order to investigate all the economic, social, ethi-
cal and organisational implications related to the adoption of the innovative three-dimensional view. With the support of a 
multi-disciplinary team, composed of eight experts working in Italian hospitals and Universities, qualitative and quantitative 
data were collected, by means of literature evidence, validated questionnaire and self-reported interviews, applying a final 
MCDA quantitative approach, and considering the dimensions resulting from the EUnetHTA Core Model.
Results From systematic search of literature, we retrieved the following studies: 9 on general surgery, 35 on gynaecology 
and urology, both concerning clinical setting. Considering simulated setting we included: 8 studies regarding pitfalls and 
drawbacks, 44 on teaching, 12 on surgeons’ confidence and comfort and 34 on surgeons’ performances. Three-dimensional 
laparoscopy was shown to have advantages for both the patients and the surgeons, and is confirmed to be a safe, efficacious 
and sustainable vision technology.
Conclusions The objective of the present paper, under the patronage of Italian Society of Endoscopic Surgery, was achieved 
in that there has now been produced a scientific report, based on a HTA approach, that may be placed in the hands of surgeons 
and used to support the decision-making process of the health providers.
Keywords Three-dimensional vision · Laparoscopy · Surgery · Health technology assessment · Systematic review
The introduction of new technologies into the healthcare sys-
tems should be guided frequently by qualitative approaches, 
since the relation between manufactures/suppliers and 
physicians is not economically sustainable [1] without an 
empirical and scientific investigation of all the possible 
benefits and disadvantages related to implementation of the 
innovation. As recommended by evidence-based medicine 
issues, efficacy and safety information are mandatory for the 
introduction of a new technology [2]. In recent years, other 
dimensions have acquired great importance, since a technol-
ogy assessment could not consist only of cost-effectiveness 
aspects [3]. This is the reason for the growing attention on 
health technology assessment (HTA), an instrument useful 
in guiding the introduction of all healthcare technologies, 
related to the evaluation of economic, ethical, social, legal 
and organisational dimensions consistent with clinical gov-
ernance tools. Health technology assessment (HTA) is a part 
of decision-making process in health system and could be 
considered as a form of policy research and as a source of 
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good evidence and at the meantime that is embedded in fur-
ther public and professional policy process.
HTA may also be considered as a support in the dialogue 
between clinicians and healthcare providers [4] and has been 
verified in the surgical context, where innovation plays a 
key role; in particular, minimally invasive surgery where, 
although it requires technological advancement and costly 
devices to be performed [5], it has proven to be effective in 
many fields of general, urologic and gynaecologic surgery. 
One such new technology in laparoscopy uses a new vision 
method, three-dimensional viewing (3D) that responds to 
the exigency of improving two-dimensional systems (2D), 
advancing towards a more realistic standard and closer to 
“open surgery” vision. However, while 3D systems are now 
emerging in the surgical market, as an improvement on 2D 
systems, they are still not widely disseminated, even though 
they are used in other non-medical fields.
Moving on from these premises, SICE (Società Itali-
ana di Chirurgia Endoscopica e nuove tecnologie—Ital-
ian Society of Endoscopic Surgery and new technologies, 
which is affiliated to the European Society of Endoscopic 
Surgery—EAES), has focused its attention on 3D laparo-
scopic technologies within the Italian surgical setting, by 
means of a specific survey devoted to SICE affiliates. Sixty-
two practices (university and community hospitals, with a 
private and public ownership) reported that 3D laparoscopy 
could be a favourable surgical strategy both for surgeons and 
for patients (65% of responders) and 82% of the surgeons 
involved in the survey reported that 3D could be considered 
the “future” of laparoscopy.
As a result, the SICE directory created a multi-discipli-
nary team (composed of surgeons selected by SICE, operat-
ing theatre nurses selected by Italian Association of Operat-
ing Theater Nurses—AICO, healthcare sector researchers 
from LIUC Cattaneo University, managerial engineers from 
Milan Politecnico, HTA experts from Lombardy Region, 
methodology experts and statisticians from Mario Negri 
Institute for Research), with the aim of producing a scientific 
report based on a HTA approach.
The objective of the present paper is the evaluation of the 
3D technology compared with that of the 2D technology in 
the settings of general, urologic and gynaecologic surgery, 
and in various procedures, using a full HTA evaluation.
Methods
To achieve the above-mentioned objective, a health tech-
nology assessment was implemented. The evaluation was 
based on the generally accepted “Core Model” developed 
by the EUnetHTA Consortium [6], deploying 9 dimen-
sions (version 2.1, April 2015) and considering the related 
criteria of evaluation derived from the Lombardy Region 
technologies assessment institutional approach [7].
The following dimensions were examined: general rel-
evance of the pathologies (description of the diseases in 
which the technology could influence the outcome) and 
technologies (comparison of the characteristics of the 
existing 2D and 3D systems), safety issues (morbidity, 
intraoperative blood loss, safety and drawbacks of sur-
geons), efficacy, economic impact (activity-based cost 
analysis and budget impact analysis), equity, ethical and 
social impact, legal issues, and organisational impact (hos-
pital stay, comfort for the surgeons, operating time and 
learning curve). This process was conducted considering 
the following setting: general surgery, gynaecology, urol-
ogy, ongoing studies, teaching, pitfalls and drawbacks, 
surgical skills and comfort of the surgeon.
Ad hoc questionnaires were created and administered to 
a pool of Italian “surgical opinion” leaders (N = 8) in order 
to investigate their perceptions concerning equity, ethical, 
social, organisational and legal implications comparing 
2D and 3D systems. The questionnaires were structured 
in accordance with a 7-item Likert scale ranging from − 3 
(worse impact) to + 3 (better impact).
To obtain safety, efficacy and organisational dimen-
sions, a systematic review of the literature evidence was 
carried out for each clinical or simulated, respectively, 
using PICO [9], PRISMA [10] and Cochrane methodolo-
gies [11]. PubMed, Scopus and Cochrane databases were 
systematically searched up to July 2016 for published ran-
domised clinical trials, observational studies and meta-
analyses of the selected setting and interventions.
We used the following terms and also their MESH 
term(s), if available: 3D, three-dimensional, 2D, two-
dimensional, surgery, laparoscopy. We combined this 
search with each relevant setting (clinical or simulated) 
and their specific terms for the following categories: gen-
eral surgery, gynaecology and urology, surgeons’ confi-
dence and comfort, pitfalls and drawbacks, surgeons’ per-
formances and teaching.
We also systematically searched the following registries 
up to May 2016: http://www.clinicaltrials.gov, http://www.
clinicaltrialsregister.eu, http://www.anzctr.org.au, to detect 
ongoing studies aimed to compare 3D vs. 2D approaches.
All studies were classified using the table ‘Levels of 
Evidence Oxford Centre for Evidence-Based Medicine 
2011’ to assess the role of each publication in terms of 
evidence generated.
After the medical database and registry searches, two 
reviewers, one surgeon and one methodologist, indepen-
dently screened abstracts and full texts, and separately pro-
ceeded with data extraction. Discrepancies were solved by 
consensus.
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Results
Comparison of the technologies under assessment
A comparative analysis of technologies between 2D and 3D 
systems used in the Italian market was undertaken using 
the technical characteristics provided by manufacturers/sup-
pliers. Four different providers of the new 3D technology 
were contacted and, upon request, made available data on 
the standard 2D and the new 3D equipment. No significant 
differences were found between the various 2D systems. 
All the 3D technologies utilised full-HD 3D (≥ 1920 × 1080 
pixels) with a 26″–32″ monitor. All systems were provided 
with “light and comfortable” passively polarized glasses and 
did not require synchronisation with the video images (as 
with earlier 3D systems [33]). The main characteristics of 
2D and 3D systems (visual resolution, images distribution 
and optics) were comparable and superimposable. The sys-
tems consisted of a camera, monitor, light source and image 
processor: no collateral accessories were considered in the 
comparative cost and performance analysis. Data on median 
costs of the laparoscopic columns (based on the industries’ 
sales catalogues) were 64,774.36 euro for the 2D column 
and 107,577.54 euro for the 3D column. Data on dissemi-
nation of the 3D systems in Italy showed a penetration in 
Italian surgical units of around 15% (from a total of 876 sur-
gical units, data extracted from an Italian national database 
[34]). Also considered was that the potential penetration of 
the new technology could reach approximately 100%, since 
all surgical units in Italy have a 2D laparoscopic column in 
their operating theatres.
Efficacy, safety and organisational results: evidence 
from the literature review
Seven systematic reviews were accomplished, each sup-
ported by 8–44 papers (comprehending systematic reviews, 
randomised controlled studies, comparative studies or pro-
spective–retrospective cohort studies) after a selection by 
titles and abstract, removal of duplicates and exclusion of 
non-pertinent studies after full-text retrieval, as shown by 
Prisma flow diagrams in Online Appendix 1. Summary 
of findings and results for each selected study have been 
drafted and the data were summarised for each EuNetHTA 
dimension.
General relevance of the pathology
The relevance of the health problem was determined by 
comparing articles related to different operations for 3D vs. 
2D laparoscopy in the three settings of general, urologic 
and gynaecologic surgery. The analysed operations were 
cholecystectomy, colectomy, adrenalectomy, hepatic resec-
tion, pulmonary resection, obesity surgery in the context of 
general surgery; hysterectomy and pelvic lymphectomy for 
gynaecological surgery; radical transperitoneal and retrop-
eritoneal prostatectomy, pyeloplasty, urethroplasty and radi-
cal cystectomy for urologic surgery. A hypothetical repre-
sentative pool of patients, who had undergone these surgical 
procedures, was defined as a general case mix of a standard 
and generic Italian hospital. The hypothesised case mix was 
derived from a recent survey performed in Campania Region 
[18]. In this specific setting, in the year 2014, 8566 patients 
underwent some kind of general, gynaecologic or urologic 
surgery. Out of these, 3544 patients (41.38%) underwent one 
of the laparoscopic operations described (Table 1).
Evaluation of outcomes
Two clinical settings and 4 simulated settings were explored:
• 3D vs. 2D in the clinical setting of general surgery: 9 
comparative studies (4 randomised controlled studies—
RCTs) out of 235 screened papers;
• 3D vs. 2D in the clinical setting of gynaecology and urol-
ogy: 35 comparative studies (1 systematic review—SR 
and 12 RCTs) out of 667 screened papers;
• 3D vs. 2D, pitfalls and drawbacks in simulated settings: 8 
comparative studies (5 RCTs) out of 56 screened papers;
• 3D vs. 2D, value in teaching for simulated settings: 44 
comparative studies (1 SR and 36 RCTs) out of 267 
screened papers;
• 3D vs. 2D, surgeons’ confidence and comfort: 12 com-
parative studies out of 187 screened papers;
• 3D vs. 2D, surgeons’ performances in the simulated set-
ting: 34 studies (1 SR and 26 RCTs) out of 149 screened 
papers.
Significativity was investigated with Excel’s descriptive 
Statistics tool (Microsoft®).
Results in clinical settings concerning morbidity reported 
a significant difference in urinary continence favouring 3D 
in radical prostatectomy and cystectomy (p < 0.02 and 0.05), 
and a substantial overlap in safety issues for other surgeries.
Table 1  Case mix in laparoscopic surgery in a recent audit from a 
high-volume hospital in Regione Campania
Surgical field No. of patients (%)
General surgery 2567 (72.4%)
Gynaecology 163 (4.6%)
Urology 814 (23.0%)
Total 3544 (100%)
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Haemorrhages were significantly lower for 3D pelvic 
lymphectomy (38 vs. 65 ml, p = 0.033) and radical prosta-
tectomy (p < 0.05), though similar in other surgical contexts.
The surgeons’ safety and comfort in the clinical setting 
had been examined only by three Italian studies [12–15] and 
demonstrated a significant advantage in terms of less visual 
fatigue and neck pain in 3D laparoscopy. Simulated settings 
failed to show statistically significant differences in the sur-
geons’ perspective between the two visual systems, even if 
results seemed inverse favouring the 2D setting but with a 
discomfort (in particular, related to dizziness and physical 
discomfort, worse in the 3D setting in 2 out of 19 studies 
[16, 17]) that was described as “tolerable”.
The efficacy value used in the analysis was the operating 
time, related to the two comparators. No significant differ-
ences emerged in the clinical setting of general surgery, even 
if 3D seemed to shorten the median time. This was par-
ticularly evident in laparoscopic cholecystectomy and when 
isolating the subgroup of “non-expert” or novice surgeons, 
in which the operating time significantly shortened.
To evaluate the organisational impact for general surgery, 
the differences in operating time were recalculated in terms 
of median values, considering only the articles with a sig-
nificant difference between 2D and 3D (Tables 2 and 3). 
Tables 2 and 3 show a significant advantage in implementing 
the 3D technologies, both in general surgery and urology. 
However, no significant differences were found within the 
ob-gyn setting. These results, deriving from the literature 
evidence, were the differential values (if reported) used in 
the budget impact analysis in order to estimate the overall 
economic savings assuming the hospital point of view.
Hospitalisation
No significant differences were found between 2D and 3D 
technologies considering the hospital stay.
Surgeons’ comfort
Significant differences were observed in depth perception 
[16, 19–22] and eye–hand coordination [23, 24], favouring 
the 3D approach.
Surgeons’ performance
The experimental setting reported better performances 
(speed, accuracy) with 3D vision, both in the expert and in 
the novice surgeons [19, 21, 25–29]. The reduction in time 
was related to various tasks at the simulator (peg transfer, 
shape, and paper cutting, suturing, rope passing, needle cap-
ping), all statistically significant, and some studies evidenced 
a reduction of the error rate [31]. This is particularly signifi-
cant for the novice surgeons [20, 32] who are able to perform 
difficult tasks more easily and feel more comfortable, and 
reflects on learning curves with a significant advantage in 
the performance of the surgical practices overall. Collat-
eral effects (nausea, eye fatigue, visual disturbances) did not 
show any statistical difference between the two technologies.
Economic dimension
Since no evidence was found concerning the economic 
impact of 3D technology (from 42 records screened, 27 
articles assessed, 27 articles excluded), this dimension was 
investigated through the implementation of an activity-based 
cost analysis (ABC) [35–37], considering a 12-month time 
horizon and assuming the hospital point of view. In particu-
lar, the economic evaluation of each patient undergoing a 
surgical procedure considered both the “surgical pathway” 
and the “medical pathway” in terms of length of stay, labo-
ratory tests and other diagnostic procedures. Data included 
direct costs of personnel working in the operating theatre 
(surgeons, nurses, anaesthetists, auxiliary personnel and 
technical staff).
The median cost of the surgical pathway (divided in 
operating room costs and personnel costs) and of medical 
pathway is summarised in Table 4. It had been established 
that the median life of a laparoscopic column is approxi-
mately 8 years that provided a cost per year of 8.096,80 euro 
for the 2D system, and 13.447,19 euro for the 3D system. 
A patient’s related cost for the two technologies is shown 
in Table 5. The ABC, in the analysed/optimised context, 
reported savings ranging from 1.173 to 1.341% per year, in 
urology and general surgery, while an increase of 0.232% of 
cost per year was realised in gynaecology.
Table 2  Operating times in general surgery
Authors 2D 3D Difference (min) Difference (%)
Velayutham et al. [42] 284 225 − 59 − 20.77
Sahu et al. [43] 54 40 − 14 − 25.93
Currò et al. [12] 60 48 − 12 − 20.00
Bilgen et al. [39] 30 20 − 10 − 33.33
Yang et al. [44] 107 86 − 21 − 19.63
Currò et al. [12] 100 88 − 12 − 12.00
Median value − 21.94
Table 3  Operating times in Urology
Fonte 2D 3D Difference (min) Difference (%)
Aykan et al. [45] 190 131 − 59 − 31.05
Xu et al. [46] 124 106 − 18 − 14.52
Bove et al. [40] 241 162 − 79 − 32.78
Tang et al. [41] 150.6 133.1 − 17.5 − 11.62
Median value − 22.49
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From a budget impact point of view, the introduction of 
a new health technology in a specific setting needs a budget 
impact analysis (BIA) to support the policy makers’ deci-
sions, in different contexts, from health system regulation 
to the hospital sustainability, both settings with limited eco-
nomic resources [38]. In this case, laparoscopic operations 
were compared, presuming that they would all be performed 
using either 2D or 3D technology, in the same context (high-
volume hospital with all medical specialties) as analysed 
previously. Over 1 year of activity of the three surgical 
branches, the adoption of a 3D system of vision would lead 
to an economic saving of 255,035.05 euro (− 12,451%), 
based on a reduction in the operating time.
To ensure the robustness of the results, a sensitivity anal-
ysis was performed, by changing the data on the reduction 
of the operating time using 3D technology, based on the 
level of evidence and recommendation of the literature data. 
In particular, data extracted from articles regarding general 
surgery, general and gynaecologic surgeries were classified 
with a strength between 1 and 2 (randomised controlled 
studies and meta-analysis [12, 13, 39, 40]), and general and 
gynaecologic surgery classified between 3 and 4 (compara-
tive non-randomised or case series [42–46]). Results of the 
budget impact sensitivity analysis confirmed the conveni-
ence of the 3D systems, with economic advantages ranging 
from 1.14 to 1.37%.
Organisational, equity, ethical, social and legal 
impacts: evidence from the professionals’ 
perceptions
These dimensions were investigated with the support of 
qualitative questionnaires administered to experts in the field 
of surgery. The results are summarised in Table 6.
With regard to the qualitative assessment of the organi-
sational dimension, it emerged that, over a time horizon of 
12 months, the introduction of the innovative technology 
required the institutionalisation of specific training courses 
devoted to the healthcare professionals and support staff 
directly involved in the procedure. These had a positive 
impact on both the internal and the purchasing processes. 
Furthermore, the innovative technology could be considered 
as the preferable surgical strategy, in particular for its ability 
to accelerate the learning curve of the operators involved 
and its manageability, thus positively affecting the operating 
theatre time.
From an equity point of view, the adoption of the innova-
tive technology would generate health migration phenomena 
and would lead to a significant decrease in waiting lists, 
Table 4  Surgical and medical 
pathway hospital cost Surgical field Surgical pathway (devices)
Surgical pathway 
(human resources)
Medical pathway Total
General surgery €3294.57 €357.64 €2148.00 €5800.21
Gynaecology €1505.63 €283.79 €2685.00 €4474.42
Urology €3229.72 €320.72 €2416.50 €5966.94
Table 5  Comparative costs per patient per year
Surgical field No. of patients 2D system 3D system
General surgery 2567 €1.00 €1.67
Gynaecology 163 €15.78 €26.21
Urology 814 €3.16 €5.25
Table 6  Professionals’ perception regarding organisational, equity, 
ethical, social and legal aspects
Item 3D system
Organisational aspects Additional staff required 0.857
Staff training − 0.571
Support staff training − 0.429
Investment in additional areas 0.571
Investment in additional 
equipment
0
Impact on the purchasing 
processes
0.286
Organisational changes 0.429
Product manageability 1.714
Improvement in the learning 
curve
1.714
Average value 0.508
Equity aspects Acceptability of the technol-
ogy
1.875
Knowledge of the technology 0
Hospital waiting list − 0.5
Accessibility 0.375
Health migration phenomena 1
Average value 0.55
Ethical and social aspects Patients’ autonomy preserva-
tion
0.5
Impact on social costs 0.88
Impact on post-operative pain 0.5
Impact on the patients’ 
satisfaction
0.88
Impact on the development of 
surgical complications
1.63
Average value 0.875
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thus improving access to care in order to meet the citizens’ 
health needs.
With regard to the ethical and social impact, clinicians 
declared that patients were able to experience a positive 
impact from the use of the innovative technology due to a 
decrease in the post-surgical pain procedure and to a lower 
risk in developing future complications.
The analysis of the legal implications reported that the 
two technologies under assessment could be considered 
superimposable in their measurement, both considering the 
indication of use for all the surgical procedures and for all 
the categories of patients, and the presence of authorisations 
for use.
Discussion and conclusions
The development of laparoscopic surgery, over the past 
20 years, has improved the outcomes of patients by reduc-
ing surgical trauma, hospital stay, post-operative pain and 
performance status. However, laparoscopy is more difficult 
to perform and to apprehend, mainly due to two-dimen-
sional vision, limited movements and instrumentation, and 
impaired tactile feedback.
To bypass some of these problems, research has turned 
to three-dimensional vision, applied per se or associated 
to robotic platforms. To date, there have been few clinical 
trials as 3D platforms are poorly disseminated in surgical 
practices, mainly due to cost-containment reasons. Clinical 
guidelines and consensus conferences are not sufficient in 
order to validate the introduction of a new surgical tech-
nology: the sustainability and the economic impact, associ-
ated with the evidence of a clinical improvement (related 
both to the patients and the operators) requires an in depth 
examination.
A strategic tool that could overcome the above-mentioned 
limitations is the health technology assessment (HTA). How-
ever, it would require a new common language to be shared 
between physicians, engineers, managers and healthcare 
providers.
The present paper may be considered as the first attempt 
to produce a complete HTA report within the surgical field, 
as a multi-disciplinary exercise involving all the profession-
als, under the patronage of the Italian Society of Endoscopic 
Surgery and new technologies (SICE), an affiliate of the 
European Association of Endoscopic Surgery (EAES).
Results of the clinical trials favour 3D vision in terms 
of blood loss, operative time and hospital stay (though 
the main results, regarding comfort for the surgeon, have 
been investigated in simulated settings that have shown 
a better depth perception, hands–eyes coordination and 
accuracy). The performances, in particular for novice sur-
geons, appear to be improved using 3D vision, with faster 
and more precise resolution of laparoscopic tasks. Sensa-
tions of neck and back pain, physical fatigue, nausea and 
dizziness have different rates between the clinical setting 
(in which they appear to be worse for 3D vision) and the 
simulated setting (in which they ameliorate for 3D vision), 
even if the worse results seem to be associated with earlier 
3D systems and lose significance in the later ones.
All this suggested that there was a need for further 
studies and investigation in order to better point out such 
drawbacks.
In this view, literature reported 14 ongoing clinical 
trials related to this topic (http://www.clinicaltrials.gov, 
https://www.clinicaltrialsregister.eu, http://www.anzctr.
org.au), 12 of which are RCTs, starting between January 
2010 to March 2015 and that are distributed throughout 
Europe (5), America (2) and Asia (7). Of these, five have 
been completed but their results have not yet published, 
seven are still recruiting and two are not yet recruiting. 
Their research is focused on laparoscopic cholecystectomy 
(4), hernia repair (2), colectomy (1), pancreatectomy (1), 
gastric surgery (1), transanal endoscopic microsurgery (1), 
gynaecologic–urologic pelvic surgery (2) and laparoscopy 
in general (2). Results are expected by 2020.
The multi-dimensional evaluation suggested, as per-
ceived by Italian surgeons in the ex-ante survey, some 
advantages of the implementation of the new technology, 
without the need of significant economic additional invest-
ment for the Healthcare Systems. The economic assess-
ment, in fact, reports how the implementation of the new 
technology, in particular if considered whenever a renewal 
of the laparoscopic instrumentation is programmed, would 
not require additional investment, thus resulting in a sub-
stantial economic neutrality and sustainability. Further-
more, 3D vision could be considered not only a privilege 
for centres of excellence, but instead the norm, applicable 
in most different realities of public or private healthcare 
contexts.
Finally, it should be mentioned that the present study 
has limitations; for example, the surveys and the consensus 
were related specifically to surgical experts, without par-
ticipation of other subjects who nowadays also take part 
in health decisions, such as patients’ associations [8, 30].
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